Gunter joins life sciences leaders to ring NYSE closing bell, honor Biotech Month
The NC Life Sciences Organization joined fellow life science trade organizations from across the country to ring the closing bell at the New York Stock Exchange Wednesday, Jan. 3, and kick off Biotech Month.
NCLifeSci President Laura Gunter was among the 16 leaders in attendance at the event, which was held jointly by NewYorkBIO and NYSE to celebrate the link between investment and innovation to best serve patients nationwide.
"The NC Life Sciences Organization was thrilled to be part of this exciting kick-off to 2024 and always welcomes a chance to collaborate with our colleagues across the country," Gunter said.
“Nationwide collaboration is crucial to driving innovation, finding cures, and ultimately improving health outcomes and quality of life for patients,” said Jennifer Hawks Bland, CEO of NewYorkBIO. “As the worldwide epicenter for the financial sector, New York is uniquely positioned as a nexus for connecting the biosciences industry with the capital that makes groundbreaking research and development possible. NewYorkBIO is grateful to NYSE for this opportunity to welcome our colleagues from across the country to Wall Street, as we bring new meaning to ‘ringing in the new year’ and kick off Biotech Month.”
The event is one of several ongoing collaborations between NewYorkBIO and NYSE, who work together to connect New York’s robust investor community with innovative life science organizations of all types and sizes.
“We are thrilled to host NewYorkBIO and life sciences leaders from across the U.S. at the NYSE to ring our Closing Bell in honor of Biotechnology Month,” said Michael Harris, global head of capital markets at the New York Stock Exchange. “As we continue to see growth in the life sciences industry, the NYSE looks forward to welcoming many more biotech companies to our community of icons and disruptors.”
- Gunter joined the following leaders from life science organizations across the country:
- Nick Shipley, chief advocacy officer at BIO
- Michele Oshman, vice president for external affairs at BIO
- Chris Molineaux, president & CEO of Life Sciences Pennsylvania
- Debbie Hart, president & CEO of BioNJ
- Elyse Blazevich, president & CEO of Colorado BioScience Association
- Eddie Pauline, president & CEO of Ohio Life Sciences
- Jodie Gillon, president & CEO of BioCT
- John Conrad, president & CEO of Illinois Biotechnology Innovation Organization
- Joni Ekstrum, executive director of South Dakota Biotech
- Kelly Schulz, CEO of Maryland Tech Council
- Kendalle Burlin O’Connell, president & CEO of MassBio
- Maria Thacker, president & CEO of Georgia Bio
- Michael Fleming, president of Delaware BioScience Association
- Mike Guerra, president & CEO of California Life Sciences
First introduced by President Bill Clinton in 2000, National Biotechnology Month is an opportunity for the nation’s biotech community to come together to recognize the industry’s achievements on behalf of patients around the world. Falling in January, the recognition month is also an opportunity for industry leaders to look ahead to the advancements of the upcoming year.
